Search research articles
Contact Us
Filters
Showing results (21-30 of 86) with videos related to
Page
of 9
Sort By:
Carcinogenesis
|
November 7, 2017
A potent hydroxamic acid-based, small-molecule inhibitor A452 preferentially inhibits HDAC6 activity and induces cytotoxicity toward cancer cells irrespective of p53 status
Hyun-Wook Ryu, Dong-Hee Shin, Dong Hoon Lee, et al.
Toxicological Research
|
July 25, 2022
Phosphodiesterase 11 A (PDE11A), a potential biomarker for glioblastoma
Hyunji Lee, Sungjin Park, Gyeyeong Kong, et al.
Toxicological Research
|
January 25, 2021
Beneficial effects of <i>Diplectria barbata</i> (Wall. Ex C. B. Clarke) Franken et Roos extract on aging and antioxidants in vitro and in vivo
Youngeun Hong, Hyunji Lee, Quangdon Tran, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 22, 2020
Advances in histone demethylase KDM4 as cancer therapeutic targets
Dong Hoon Lee, Go Woon Kim, Yu Hyun Jeon, et al.
Journal of Proteomics
|
April 1, 2014
Analysis of the heterochromatin protein 1 (HP1) interactome in Drosophila
Hyun-Wook Ryu, Dong Hoon Lee, Laurence Florens, et al.
Experimental & Molecular Medicine
|
December 12, 2022
Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis
Jung Yoo, Go Woon Kim, Yu Hyun Jeon, et al.
Genes & Development
|
October 5, 2010
Heterochromatin protein 1 (HP1) connects the FACT histone chaperone complex to the phosphorylated CTD of RNA polymerase II
So Hee Kwon, Laurence Florens, Selene K Swanson, et al.
Frontiers in Molecular Biosciences
|
April 12, 2021
Corrigendum: Current Knowledge on the Function of α-Methyl Acyl-CoA Racemase in Human Diseases
Gyeyeong Kong, Hyunji Lee, Quangdon Tran, et al.
Molecular Carcinogenesis
|
June 20, 2018
A452, an HDAC6-selective inhibitor, synergistically enhances the anticancer activity of chemotherapeutic agents in colorectal cancer cells
Hye-Rim Won, Hyun-Wook Ryu, Dong-Hee Shin, et al.
International Journal of Oncology
|
July 4, 2019
HDAC6‑selective inhibitor synergistically enhances the anticancer activity of immunomodulatory drugs in multiple myeloma
Hye-Rim Won, Dong Hoon Lee, Soo-Keun Yeon, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 86) with videos related to
Sort By:
Page
of 9
Carcinogenesis
|
November 7, 2017
A potent hydroxamic acid-based, small-molecule inhibitor A452 preferentially inhibits HDAC6 activity and induces cytotoxicity toward cancer cells irrespective of p53 status
Hyun-Wook Ryu, Dong-Hee Shin, Dong Hoon Lee, et al.
Toxicological Research
|
July 25, 2022
Phosphodiesterase 11 A (PDE11A), a potential biomarker for glioblastoma
Hyunji Lee, Sungjin Park, Gyeyeong Kong, et al.
Toxicological Research
|
January 25, 2021
Beneficial effects of <i>Diplectria barbata</i> (Wall. Ex C. B. Clarke) Franken et Roos extract on aging and antioxidants in vitro and in vivo
Youngeun Hong, Hyunji Lee, Quangdon Tran, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 22, 2020
Advances in histone demethylase KDM4 as cancer therapeutic targets
Dong Hoon Lee, Go Woon Kim, Yu Hyun Jeon, et al.
Journal of Proteomics
|
April 1, 2014
Analysis of the heterochromatin protein 1 (HP1) interactome in Drosophila
Hyun-Wook Ryu, Dong Hoon Lee, Laurence Florens, et al.
Experimental & Molecular Medicine
|
December 12, 2022
Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis
Jung Yoo, Go Woon Kim, Yu Hyun Jeon, et al.
Genes & Development
|
October 5, 2010
Heterochromatin protein 1 (HP1) connects the FACT histone chaperone complex to the phosphorylated CTD of RNA polymerase II
So Hee Kwon, Laurence Florens, Selene K Swanson, et al.
Frontiers in Molecular Biosciences
|
April 12, 2021
Corrigendum: Current Knowledge on the Function of α-Methyl Acyl-CoA Racemase in Human Diseases
Gyeyeong Kong, Hyunji Lee, Quangdon Tran, et al.
Molecular Carcinogenesis
|
June 20, 2018
A452, an HDAC6-selective inhibitor, synergistically enhances the anticancer activity of chemotherapeutic agents in colorectal cancer cells
Hye-Rim Won, Hyun-Wook Ryu, Dong-Hee Shin, et al.
International Journal of Oncology
|
July 4, 2019
HDAC6‑selective inhibitor synergistically enhances the anticancer activity of immunomodulatory drugs in multiple myeloma
Hye-Rim Won, Dong Hoon Lee, Soo-Keun Yeon, et al.
Page
of 9